Purified Recombinant VP2 Protein Can Provide Complete Protection to very Virulent Infectious Bursal Disease Virus Challenge as a Subunit Vaccine

• Egile Nagusiak: Pang Wenqiang (Egilea), Zhao Kunkun (Egilea), Xue Jingjing (Egilea), Geng Xiaolin (Egilea), Yuan Yue (Egilea), Huang Yuxin (Egilea), Yang Yujie (Egilea), Jin Yudan (Egilea), Tian Hui (Egilea), Wu Peng (Egilea), Li Xiangdong (Egilea), Liu Wujie (Egilea), Tian Kegong (Egilea)
• Formatua: Liburua
• Argitaratua: Journal of Vaccines and Immunology - Peertechz Publications, 2015-10-05.
• Gaiak: Research Article
• Sarrera elektronikoa: Connect to this object online.

<p><strong>Background:</strong> The very virulent infectious bursal disease virus has become the dominant path type that damage lymphoid tissues with high mortality in young chickens in China. Current commercial vaccines are modified live vaccines originated from classic form of vi...